Trinity Ventures leads Series A round for biotech software firm Cyrus
Seattle-based Cyrus Biotechnology Inc, biotechnology software firm, has raised $8 million in Series A financing. Trinity Ventures led the round with participation from other investors that included OrbiMed Advisors, SpringRock Ventures and W Fund.
27 July 2017•1 min read
